Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MR Syringe Dual Pack for Solaris Injectors

K-Number: K161471 · 2016-10-06

ApplicantCoeur, Inc.
Decision Date2016-10-06
Product CodeDXT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

MR Syringe Dual Pack for Solaris Injectors is the device name listed in this FDA 510(k) record. The listed applicant is Coeur, Inc.. It received FDA 510(k) clearance on 2016-10-06 under 510(k) number K161471. The device is classified under product code DXT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MR Syringe Dual Pack for Solaris Injectors?

MR Syringe Dual Pack for Solaris Injectors is a medical device that received FDA 510(k) clearance on 2016-10-06. The listed applicant is Coeur, Inc.. The 510(k) number is K161471.

When did MR Syringe Dual Pack for Solaris Injectors receive FDA 510(k) clearance?

MR Syringe Dual Pack for Solaris Injectors received FDA 510(k) clearance on 2016-10-06, under 510(k) number K161471.

Who is the listed applicant for MR Syringe Dual Pack for Solaris Injectors?

The FDA 510(k) record lists Coeur, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MR Syringe Dual Pack for Solaris Injectors?

The FDA product code for MR Syringe Dual Pack for Solaris Injectors is DXT.

Other records listing Coeur, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DXT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.